Evidence map›Paper›PMID 24849599›Full record

ArticleThe Journal of biological chemistry2014

Molecular cloning and functional characterization of components of the capsule biosynthesis complex of Neisseria meningitidis serogroup A: toward in vitro vaccine production.

Timm Fiebig, Friedrich Freiberger, Vittoria Pinto, Maria Rosaria Romano, Alan Black, Christa Litschko, Andrea Bethe, Dmitry Yashunsky, Roberto Adamo, Andrei Nikolaev and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Chemical Synthesis of Oligosaccharides Derived fromJournal of the American Chemical Society · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Biosynthesis of UDP-α-Biochemistry · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Structural characterization of a nonhydrolyzing UDP-GlcNAc 2-epimerase from Neisseria meningitidis serogroup A.Acta crystallographica. Section F, Structural biology communications · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Timm FiebigFrom the Institute for Cellular Chemistry, Hannover Medical School, 30625 Hannover, Germany.
Friedrich FreibergerFrom the Institute for Cellular Chemistry, Hannover Medical School, 30625 Hannover, Germany.
Vittoria PintoNovartis Vaccines, Research, Via Fiorentina 1, 53100 Siena, Italy.
Maria Rosaria RomanoNovartis Vaccines, Research, Via Fiorentina 1, 53100 Siena, Italy.
Alan BlackCollege of Life Sciences, University of Dundee, Dundee, DD1 5EH, Scotland, United Kingdom, and.
Christa LitschkoFrom the Institute for Cellular Chemistry, Hannover Medical School, 30625 Hannover, Germany.
Andrea BetheFrom the Institute for Cellular Chemistry, Hannover Medical School, 30625 Hannover, Germany.
Dmitry Yashunskythe Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Pogodinskaya Street 10, Moscow 119832, Russian Federation.
Roberto AdamoNovartis Vaccines, Research, Via Fiorentina 1, 53100 Siena, Italy.
Andrei NikolaevCollege of Life Sciences, University of Dundee, Dundee, DD1 5EH, Scotland, United Kingdom, and.
Francesco BertiNovartis Vaccines, Research, Via Fiorentina 1, 53100 Siena, Italy, francesco.berti@novartis.com.
Rita Gerardy-SchahnFrom the Institute for Cellular Chemistry, Hannover Medical School, 30625 Hannover, Germany, gerardy-schahn.rita@mh-hannover.de.
Medizinische Hochschule Hannover · DENovartis (Italy) · ITToscana Life Sciences · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human pathogen Neisseria meningitidis (Nm) is a leading cause of bacterial meningitis and sepsis globally. A major virulence factor of Nm is the capsular polysaccharide (CPS), which in Nm serogroup A consists of N-acetyl-mannosamine-1-phosphate units linked together by phosphodiester linkages [ → 6)-α-D-ManNAc-(1 → OPO3 (-)→]n. Acetylation in O-3 (to a minor extent in O-4) position results in immunologically active polymer. In the capsule gene cluster (cps) of Nm, region A contains the genetic information for CPSA biosynthesis. Thereby the open reading frames csaA, -B, and -C are thought to encode the UDP-N-acetyl-D-glucosamine-2-epimerase, poly-ManNAc-1-phosphate-transferase, and O-acetyltransferase, respectively. With the aim to use a minimal number of recombinant enzymes to produce immunologically active CPSA, we cloned the genes csaA, csaB, and csaC and functionally characterized the purified recombinant proteins. If recombinant CsaA and CsaB were combined in one reaction tube, priming CPSA-oligosaccharides were efficiently elongated with UDP-GlcNAc as the donor substrate, confirming that CsaA is the functional UDP-N-acetyl-D-glucosamine-2-epimerase and CsaB the functional poly-ManNAc-1-phosphate-transferase. Subsequently, CsaB was shown to transfer ManNAc-1P onto O-6 of the non-reducing end sugar of priming oligosaccharides, to prefer non-O-acetylated over O-acetylated primers, and to efficiently elongate the dimer of ManNAc-1-phosphate. The in vitro synthesized CPSA was purified, O-acetylated with recombinant CsaC, and proven to be identical to the natural CPSA by (1)H NMR, (31)P NMR, and immunoblotting. If all three enzymes and their substrates were combined in a one-pot reaction, nature identical CPSA was obtained. These data provide the basis for the development of novel vaccine production protocols.

Indexed as

Meningococcal VaccinesBacterial CapsulesBacterial ProteinsCloning, MolecularHumansNeisseria meningitidis, Serogroup APolysaccharides, BacterialBacterial ProteinsMeningococcal VaccinesPolysaccharides, BacterialAcetyltransferaseCapsule PolymeraseEnzyme CatalysisEpimeraseGram-negative BacteriaNeisseria meningitidis Serogroup ANuclear Magnetic Resonance (NMR)PolysaccharideRecombinant Protein ExpressionVaccine Development

Identifiers

PMID24849599
PMCPMC4094051
OpenAlexW1981494855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.